BlackRock Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $219M | Buy |
2,967,665
+574,087
| +24% | +$42.3M | 0.1% | 230 |
|
|
2016
Q3 | $209M | Buy |
2,393,578
+57,835
| +2% | +$5.04M | 0.11% | 226 |
|
|
2016
Q2 | $201M | Buy |
2,335,743
+203,062
| +10% | +$17.5M | 0.1% | 236 |
|
|
2016
Q1 | $170M | Sell |
2,132,681
-18,268
| -0.8% | -$1.45M | 0.09% | 265 |
|
|
2015
Q4 | $271M | Sell |
2,150,949
-32,477
| -1% | -$4.09M | 0.15% | 153 |
|
|
2015
Q3 | $227M | Sell |
2,183,426
-276,580
| -11% | -$28.8M | 0.13% | 178 |
|
|
2015
Q2 | $304M | Buy |
2,460,006
+5,899
| +0.2% | +$728K | 0.17% | 141 |
|
|
2015
Q1 | $290M | Sell |
2,454,107
-11,645
| -0.5% | -$1.37M | 0.16% | 146 |
|
|
2014
Q4 | $293M | Buy |
2,465,752
+274,439
| +13% | +$32.6M | 0.16% | 144 |
|
|
2014
Q3 | $246M | Buy |
2,191,313
+164,212
| +8% | +$18.4M | 0.14% | 158 |
|
|
2014
Q2 | $192M | Sell |
2,027,101
-2,225
| -0.1% | -$211K | 0.11% | 221 |
|
|
2014
Q1 | $144M | Buy |
2,029,326
+11,177
| +0.6% | +$790K | 0.09% | 251 |
|
|
2013
Q4 | $150M | Sell |
2,018,149
-18,746
| -0.9% | -$1.39M | 0.1% | 238 |
|
|
2013
Q3 | $154M | Buy |
2,036,895
+652,783
| +47% | +$49.5M | 0.1% | 221 |
|
|
2013
Q2 | $111M | Buy |
+1,384,112
| New | +$111M | 0.08% | 267 |
|